After five intensive rounds of directed evolution, a leading biotech company had achieved an 8x increase in enzyme activity and a 12x increase in enzyme specificity. However, they had reached a plateau.
Engineered enzymes are a cornerstone of green chemistry, but their catalytic efficiency often falls short of natural enzymes. A key reason for this performance gap is that traditional optimization methods focus almost exclusively on the enzyme’s active site, neglecting the critical role that protein dynamics and distal regions play in catalysis.
To address this, researchers from the Stratingh Institute for Chemistry (University of Groningen) and Zymvol sought to prove that strategically placed mutations far from the active site could unlock new levels of performance.
For this study, the team selected an artificial enzyme based on the lactococcal multidrug resistance regulator (LmrR), which had previously reached, in different studies, a limited level of performance with only active-site mutations. This transcription factor is an ideal scaffold for designing “new-to-nature” enzymes for applications in biocatalysis, bioremediation, and biosensors.
To prove that distal mutations could enhance performance, our researchers used Zymspot, an innovative algorithm within our Zymevolver software. Zymspot’s function is to identify mutations that affect the enzyme’s conformational equilibrium and, in turn, its catalytic performance.
This approach enabled us to quickly identify key areas of the enzyme that influence its behavior. The algorithm filtered millions of possibilities down to a manageable list of just 73 potentially beneficial variants. This computational list was generated in just two days, dramatically accelerating the entire engineering process.
✱ This Success Story summarizes the results presented in a peer-reviewed research paper co-authored by scientists from the Stratingh Institute for Chemistry (University of Groningen) and Zymvol Biomodeling.